BSE filing, NSE: TORNTPHARM. Summary written from the filing by ALFA Finder's alert engine.
Torrent Pharmaceuticals Ltd: key numbers
- Share price
- ₹4,557.00
- Market cap
- ₹1,73,334 Cr
- Revenue (annual)
- ₹13,980 Cr
- Net profit (annual)
- ₹2,163 Cr
- P/E (TTM)
- 81.6×Sector 46.1×
- Promoter holding
- 60.78%-7.53% QoQ
- FII holding
- 17.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Torrent Pharmaceuticals Ltd
All →Torrent Pharmaceuticals Earnings Call Transcript: Key Takeaways
Revenue grew 51% following the JB Chemicals merger, but underlying business shows integration headwinds.
- Call
- Guides 10% growth
Torrent Pharmaceuticals Debt & Borrowing
Torrent Pharmaceuticals filed its security cover certificate as on 30-Sep-26 for listed NCDs, showing 141% market-value cover. Secured debt covered by the certificate stands at Rs 11,578.42 Crore.
Torrent Pharmaceuticals Q2 FY27 Results: Net Profit ₹534 Cr, Down 9.6% YoY
Torrent Pharmaceuticals Ltd reported revenue from operations of ₹4,979 Cr (+50.8% YoY) and net profit of ₹534 Cr (-9.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹534 Cr · -9.6% YoY
Torrent Pharmaceuticals Management Change
Torrent Pharmaceuticals' Executive Director, Amal Kelshikar, has resigned from his position effective October 16, 2026.
Torrent Pharmaceuticals Credit Rating
India Ratings affirmed Torrent Pharmaceuticals' existing credit ratings and revised the outlook to positive. The company's commercial paper rating was also affirmed and assigned.
Torrent Pharmaceuticals Board Meeting Date
Torrent Pharmaceuticals will hold a board meeting on 23-Oct-26 to consider standalone audited and consolidated unaudited financial results for the quarter and half-year ended 30-Sep-26.
Other board meeting date announcements
All →RR Securities Board Meeting Date
R R Securities Limited intimated a board meeting on 06 Nov 2026 to consider unaudited standalone results for the quarter and half year ended September 2026. Trading window closes 01 Oct to 09 Nov 2026.
Rico Auto Industries Board Meeting Date
Rico Auto Industries Limited intimated a board meeting on 06 Nov 2026 to consider unaudited standalone and consolidated half-yearly financial results for September 2026. Trading window stays closed from 01 Oct 2026 until 48 hours after results.
Oil Country Tubular Board Meeting Date
Oil Country Tubular Limited intimated a board meeting on 05 Nov 2026 to consider unaudited standalone financial results for the quarter ended September 2026. Trading window closes 01 Oct to 07 Nov 2026.
Gajanand International Board Meeting Date
Gajanand International Ltd will hold a board meeting on 4 Nov 2026 to consider unaudited H1 FY27 results. This is an advance intimation; no decision has been taken yet.
Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.